Federated Hermes, Inc. Kala Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.61 - $1.84 $40,603 - $122,475	-66,563 Reduced 96.39%	2,496 $3,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $80,108 - $189,221	69,059 New	69,059 $84,000
Q4 2020 Feb 12, 2021	SELL	$6.28 - $8.79 $315,865 - $442,110	-50,297 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$7.5 - $11.11 $1.03 Million - $1.53 Million	-137,811 Reduced 73.26%	50,297 $377,000
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $1.56 Million - $2.59 Million	187,461 Added 28973.88%	188,108 $1.98 Million
Q1 2020 May 13, 2020	BUY	$3.83 - $8.79 $2,478 - $5,687	647 New	647 $6,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.